Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.
暂无分享,去创建一个
[1] D. Carson,et al. Gene vaccination with naked plasmid DNA: mechanism of CTL priming , 1996, The Journal of experimental medicine.
[2] P. Robbins,et al. Human tumor antigens recognized by T cells. , 1996, Current opinion in immunology.
[3] C. Walker,et al. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Bevan,et al. Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. , 1996, Immunity.
[5] M. Bevan,et al. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide , 1996, The Journal of experimental medicine.
[6] C. Harding,et al. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. , 1996, Journal of immunology.
[7] E. Gilboa,et al. Induction of antitumor immunity using bone marrow-generated dendritic cells. , 1996, Journal of immunology.
[8] D. Pardoll,et al. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. , 1996, Immunity.
[9] J. Austyn. New insights into the mobilization and phagocytic activity of dendritic cells , 1996, The Journal of experimental medicine.
[10] K. Rock. A new foreign policy: MHC class I molecules monitor the outside world. , 1996, Immunology today.
[11] M. Colombo,et al. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo , 1996, The Journal of experimental medicine.
[12] J. Mayordomo,et al. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity , 1996, The Journal of experimental medicine.
[13] L. Zitvogel,et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines , 1996, The Journal of experimental medicine.
[14] N. Shastri,et al. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. , 1995, Immunity.
[15] R. Germain,et al. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis , 1995, The Journal of experimental medicine.
[16] M. Bevan,et al. Antigen presentation to cytotoxic T lymphocytes in vivo , 1995, The Journal of experimental medicine.
[17] F. Sallusto,et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.
[18] E. Gilboa,et al. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes , 1995, The Journal of experimental medicine.
[19] S. Tonegawa,et al. TAP1‐independent loading of class I molecules by exogenous viral proteins , 1995, European journal of immunology.
[20] M. Kovacsovics-Bankowski,et al. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules , 1995, Science.
[21] K. Rock,et al. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines , 1994, European journal of immunology.
[22] J. Reimann,et al. Injection of detergent‐denatured ovalbumin primes murine class I‐restricted cytotoxic T cells in vivo , 1994, European journal of immunology.
[23] E. Jaffee,et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. , 1994, Science.
[24] F. Sallusto,et al. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.
[25] S. Rosenberg,et al. Murine epidermal Langerhans cells and splenic dendritic cells present tumor‐associated antigens to primed T cells , 1994, European journal of immunology.
[26] B. Heyman,et al. In vivo enhancement of the specific antibody response via the low‐affinity receptor for IgE , 1993, European journal of immunology.
[27] R. Warn,et al. Circular ruffle formation and closure lead to macropinocytosis in hepatocyte growth factor/scatter factor-treated cells. , 1993, European journal of cell biology.
[28] M. Bevan,et al. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells , 1993, The Journal of experimental medicine.
[29] J. Pfeifer,et al. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells , 1993, Nature.
[30] R. Steinman,et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.
[31] B. Rouse,et al. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro , 1992, The Journal of experimental medicine.
[32] D. Betcher,et al. Granulocyte macrophage colony-stimulating factor , 1991, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.
[33] K. Rock,et al. Presentation of exogenous antigen with class I major histocompatibility complex molecules. , 1990, Science.
[34] R. Steinman,et al. Dendritic cells pulsed with protein antigens in vitro can prime antigen- specific, MHC-restricted T cells in situ [published erratum appears in J Exp Med 1990 Oct 1;172(4):1275] , 1990, The Journal of experimental medicine.
[35] R. Steinman,et al. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies , 1990, The Journal of experimental medicine.
[36] R. Steinman,et al. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells , 1990, The Journal of experimental medicine.
[37] R. Steinman,et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells , 1989, The Journal of experimental medicine.
[38] M. Bevan,et al. Introduction of soluble protein into the class I pathway of antigen processing and presentation , 1988, Cell.
[39] R. Steinman,et al. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro , 1979, The Journal of experimental medicine.
[40] M. Bevan,et al. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. , 1976, Journal of immunology.
[41] M. Bevan. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay , 1976, The Journal of experimental medicine.
[42] R. Steinman,et al. IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE , 1973, The Journal of experimental medicine.
[43] C. J. Borgmeyer. The St. Louis Chemical Society , 1906, Science.
[44] K. Rock,et al. Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.
[45] R. Germain,et al. The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.
[46] R. Steinman,et al. Dendritic cells: antigen presentation, accessory function and clinical relevance. , 1993, Advances in experimental medicine and biology.
[47] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.